ASX chart of the Day - MSB - Stem cell company ready for move higher again after pullback
Channel: GO Markets 
Date: 18/04/2024

Mesoblast Limited (MSB) is involved in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a portfolio of late stage product candidates.

For more information, visit our website: www.gomarkets.com

Find us on other Social Networks:
Facebook: https://www.facebook.com/GOMarkets/
Twitter: https://twitter.com/GO_Markets
LinkedIn: https://au.linkedin.com/company/go-markets
Instagram: https://www.instagram.com/gomarkets/
-
Contact us:
Email: support@gomarkets.com
International: +61 3 8566 7680
Australia: 1800 885 571
Cyprus: +357 25023910
Mauritius: +230 5869 0074
United Kingdom: +44 2036 377 618
-
The information on this website is general in nature only and doesn’t take into account your personal objectives, financial situation or needs. Before acting on the information on this website, you should consider whether the information is suitable for you and your personal circumstances and if necessary, seek appropriate professional advice. All opinions, conclusions, forecasts or recommendations are reasonably held at the time of compilation but are subject to change without notice.
GO Markets Pty Limited, ABN 85 081 864 039, AFSL 254963 is a CFDs issuer. 

Trading in CFDs carries significant risks and is not suitable for everyone. You do not own or have any interest in the rights in the underlying assets. You should consider whether you are part of our target market by reviewing our TMD and read our Product Disclosure Statement (PDS) and other CFD legal documents to ensure you understand the risks before you invest in CFDs

GO Markets Securities Pty Limited, ABN 24 653 400 527, CAR 1292963 of GO Markets Pty Limited, AFSL 254963 provides ASX and Cboe Share Trading services including Listed Investment Companies and Exchanged Traded Funds. It is important that you consider the relevant Share Trading legal documents before you decide whether or not to acquire any of the share trading services.